Horizons Hémato – Vol. 13 n°1 – Mars 2023
You don't have permission to view the content
Le Kiosque – 1er trimestre 2023
You don't have permission to view the content
Flash presse – 1er trimestre 2023
You don't have permission to view the content
Zoom congrès : ASH 2022
You don't have permission to view the content
Développements des thérapies par CAR T-cells en Europe
You don't have permission to view the content
CAR T-cells dans les nouvelles indications
You don't have permission to view the content
Quoi de neuf avec les CAR T-cells dans le traitement de la Leucémie Lymphoïde Chronique (LLC) ?
You don't have permission to view the content
Myélome Multiple et CAR T-cells : résultats des essais cliniques
You don't have permission to view the content
Leucémies aigües lymphoblastiques : CAR T-cells et anticorps bispécifiques : quelles nouvelles stratégies ?
You don't have permission to view the content
Cellules CAR T fabriquées dans des structures académiques. Situation en France
You don't have permission to view the content
French 
English 
